Presentation is loading. Please wait.

Presentation is loading. Please wait.

NATIONAL TREATMENT AGENCY

Similar presentations


Presentation on theme: "NATIONAL TREATMENT AGENCY"— Presentation transcript:

1 NATIONAL TREATMENT AGENCY
Addiction to Medicines: Understanding Public Health Commissioning Beverley Oliver & Corinne Harvey Regional Managers , NTA North East and Yorkshire and Humber and the East Middlands Slide 1

2 Workshop Programme 45mins:
5mins: Introductions from facilitators and from work shop participants. 10mins: A short presentation to describe the landscape including realistic opportunities and threats - Setting the scene . 30 mins: Small working groups to discuss and raise the poignant points for discussion - each group to feed back. 5mins: Any further questions and close From 1st April, significant structural changes to the NHS will come in to effect. These changes alter the landscape of commissioning. This presentation covers briefly the structure of the NHS post April 2013, before looking at the process around commissioning to address ATM. We will explore a number of opportunities to engage with the commissioning process and describe the support on offer. The workshop will end with an opportunity for questions and discussion. Slide 2 2

3 Contents: Understanding Public Health Commissioning
Public Health England and the Health and Care System Commissioning Process Opportunities and Support Discussion and Questions From 1st April, significant structural changes to the NHS will come in to effect. These changes alter the landscape of commissioning. This presentation covers briefly the structure of the NHS post April 2013, before looking at the process around commissioning to address ATM. We will explore a number of opportunities to engage with the commissioning process and describe the support on offer. The workshop will end with an opportunity for questions and discussion. Slide 3 3

4 Public Health England PHE will oversee all Public Health delivery, provide expert information and advice and support local public health commissioning and delivery. Public Health England will work with its partners to provide expert evidence and intelligence, and the cost-benefit analysis that will enable local government, the NHS, and the voluntary, community and social enterprise sector, among others, to: • invest effectively in prevention and health promotion so that people can live healthier lives and there is reduced demand on health and social care services, as well as on the criminal justice system • protect the public by providing a comprehensive range of health protection services • commission and deliver safe and effective healthcare services and public health programmes across the whole lifecourse and across care pathways; from prevention through to treatment, from children’s services to mental health and wellbeing, substance misuse services, screening programmes and older people’s services • ensure interventions and services are designed and implemented in ways that meet the needs of different groups in society advancing equality of opportunity between protected groups and others, and reducing inequalities. (PH, Operating Model) Slide 4 4

5 The new health and care system
Police and Crime Commissioners could have a seat. Up to each LA Local people and communities Undertake JSNA & develop HWB Strategies setting out local priorities Health and Well-being Board The evidence in this presentation can inform the JSNA and HWB Strategies. PHE Centres Local Authorities CCG/NHS CB Responsible for publishing data and supporting delivery of PHOF Commissioning OF – set by the NHS CB for CCGs HealthWatch Accountability Oversight Links Local commissioning of ATM provision, supported by PHE, will take place in the new health and social care system. Local Authority employed DsPH will lead on the commissioning of treatment for ATM, and will be supported to work closely with colleagues overseeing the treatment needs of offenders in the secure estate, NHSCB ATs. NHSCB ATs will also commission Primary Care services which have a roll to play in the control and management of ATM (could mention here the influence of the GMS contract). CCGs will support the agenda through their commissioning of advice as part of other healthcare contacts. PHE NHS CB ASCOF PHOF NHSOF Mandate – only means of holding the CB to account Sets out the indicators that the PH system & DH understand are the best mechanisms to improve public health. Up to LAs to prioritise. Secretary of State for Health Parliament Sets out the indicators that the NHS should seek to achieve through the Mandate objective of continuous improvement Slide 5 5 5

6 Commissioning Flowchart
PHE needs assessment data Public Health Grant Engagement Opportunities Local needs assessment DsPH HWBBs JSNA & HWBS ATM services commissioned by local authorities, through Directors of Public Health Supported by and coordinated through Health & Wellbeing Boards Joint Strategic Needs Assessments (JSNAs) and Joint Health and Wellbeing Strategies (JHWSs) Ring fenced public health budget (Public Health Grant) From DH & Public Health England (PHE) NTA functions transferred to PHE –April 2013 Public health outcome indicators Operational Commissioners Local Performance Management Slide 6 6

7 Commissioning Process and the role of voluntary and statutory providers
ATM services commissioned by local authorities, through Directors of Public Health - supported by and coordinated through Health & Wellbeing Boards Stronger together - describes how Health and Wellbeing Boards can work effectively with local providers is a framework for building health and wellbeing board and provider engagement • A strategic, whole system approach – setting out a clear, strategic vision of how and why providers will be actively engaged in both determining and delivering the board’s priorities.. • Clarifying the new commissioning landscape – and the benefits of the new partnerships to local providers and others. • Involving providers in determining engagement approaches – this collaboration will foster better understanding, stronger cooperation and greater enthusiasm for more productive engagement. Slide 7

8 Opportunities and Support – Health and Wellbeing Boards
Provider-led initiatives – providers themselves have and can devise effective ways of how they can jointly engage with their health and wellbeing board for mutual benefit. Providers as board members – this can be applicable where health and wellbeing boards have been established as strategic bodies rather than direct commissioning structures. A new kind of board and provider leadership is needed for all parties to work above their own organisation’s interests for the benefit of the local health and wellbeing system. Different approaches and new skills may be required. Stronger together How health and wellbeing boards can work effectively with local providers This would incorporate an audit of existing provider engagement, reviewing whether this is fit for purpose and then building new engagement where necessary Slide 8 8

9 Opportunities and Support – Health and Wellbeing Boards (continued)
Stronger together: how health and wellbeing boards can work effectively with local providers 04 • Informal peer to peer relationships are important and can be very effective engagement mechanisms outside of formal board meetings. • Market facilitation for innovation – boards will need to consult and engage with providers to stimulate service development and delivery design to better meet the needs of local populations. • Partnership links with local Healthwatch – building links between providers and Healthwatch will help to develop and create mechanisms and opportunities for engaging local communities and ensure their voices are heard on health and wellbeing boards. Effective engagement of local providers is significant to health and wellbeing boards fulfilling their role and responsibilities. If boards wish to transform, reconfigure and integrate their services to achieve improved health and wellbeing outcomes, it is essential they engage providers to make this happen. There are different mechanisms for making local provider engagement effective. Health and wellbeing boards should consider using and experimenting with a range of different approaches given the considerable variety of size and type of local providers. It will be important that no provider feels disadvantaged. Provider involvement in the design and development of engagement mechanisms will lead to stronger and more successful engagement across a board locality. Continued shared learning among health and wellbeing boards around the different engagement approaches being trialled and implemented locally will assist local areas to find the most appropriate methods to meet their engagement needs. Opportunities and Support – Health and Wellbeing Boards (continued) • Provider representation for groups, not single organisations – sitting on and engaging with health and wellbeing boards can reduce conflicts of interest, as representation is linked to a group not an individual provider, and be an effective way of feeding in provider knowledge and expertise. • Cooperative working with provider forums – health and wellbeing boards can engage with various provider forums but, to ensure proper engagement, partnership rather than consultation will be required to build collaborative working with providers. • Sub-groups of the health and wellbeing board – these groups, made up of commissioners and providers, can be effective at looking in more detail at a particular theme, care pathway or client group. 9

10 Opportunities and Support - Relationships
There is no statutory seat on the Health and Well-being Boards for voluntary and community sector representation, nor for specialist representation for the drug and alcohol sector. However, HWBs are being encouraged to involve the VCS in the development of local strategies. The draft guidance on JSNAs and JHWSs published by the Department of Health for consultation in July 2012 explained that the local VCS could be represented on the HWB, and highlighted the potential for additional members, such as the VCS, service providers, health and care professionals, and representatives of criminal justice agencies ‘to bring expert knowledge to enhance JSNAs and JHWSs’. Slide 10 10

11 Opportunities and Support - Finance
Funding for drug and alcohol misuse treatment: Drug and alcohol misuse prevention and treatment important part of public health responsibilities 34% of national spend on public health has been on substance misuse - recognised in the target formula for the public health grants - illustrates significance of the agenda Budget is the ring-fenced - but may be other local investment in services and local authorities will want to explore opportunities to lever in investment from elsewhere.  Activity and performance on drug treatment has had an impact on how much money an area has received LAs required to report spending on an annual basis.  There are categories for adult drugs, adult alcohol and YP drug and alcohol spending.  Disinvestment will be very evident Drug treatment continues to be a key priority for the government and this is unlikely to change Slide 11 11

12 Identifying and presenting ‘Need’ to Commissioners
Where can PHE support? NTA’s/PHE JSNA documents Evidence base - growing To work with local PHE Drug and Alcohol teams in how to inform and influence planning (who, where, how?) Have your input via JSNA (contributing local data/intelligence) Support with case studies and local practice examples Scope and be aware of what contracts/funding may become available (ads/tenders primarily but could involve prime provider and subs, integrated services, etc.) Consider working with other providers to prepare joint tenders where appropriate Other solutions such as offering yourself as a sub-contractor Keeping in mind other relevant sources of funding: mental health (CCGs), voluntary sector (LA, charitable trusts, Lottery, companies, etc.) NTA’s/PHE JSNA documents to provide support Acknowledge and challenge that the NTA/PHE JSNA materials DO NOT  ‘instruct’ local areas to only commission combined provision for drugs, alcohol and ATM and this is misconception. Reminder of the evidence base (although this is limited) Support engagement with commissioners  how to inform and influence planning (who, where, how?) To have their input via JSNA (contributing local data/intelligence) Add in local practice examples (if we can) How contracts/funding may become available (ads/tenders primarily but could involve prime provider and subs, integrated services, etc.) Working with other providers to prepare joint tenders where appropriate Solutions such as: Offering yourself as a sub-contractor Keeping in mind other relevant sources of funding: mental health (CCGs), voluntary sector (LA, charitable trusts, Lottery, companies, etc.) 12

13 Context: Suite of evidence-based clinical guidance 2007
NICE guidance 13

14 Has anyone been to the skills consortium website.
14

15 Thank you for your time and any questions?
Slide 15


Download ppt "NATIONAL TREATMENT AGENCY"

Similar presentations


Ads by Google